Gonadotropin Releasing Hormone Receptor Agonist class drugs
4 results
Fensolvi (leuprolide acetate)
(Leuprolide Acetate)TOLMAR Inc.
Usage: FENSOLVI is indicated for treating central precocious puberty (CPP) in pediatric patients aged 2 years and older.
Fensolvi (leuprolide acetate)
(Leuprolide Acetate)TOLMAR Inc.
Usage: FENSOLVI is indicated for the treatment of central precocious puberty (CPP) in pediatric patients aged 2 years and older.
Lupron depot (leuprolide acetate)
(leuprolide acetate)AbbVie Inc.
Usage: LUPRON DEPOT 11.25 mg is indicated for managing endometriosis (pain relief and lesion reduction) and, when combined with norethindrone acetate, for symptom management. It also prepares women with anemia due to uterine fibroids for surgery, enhancing hematologic improvement alongside iron therapy. Total therapy duration should not exceed 12 months.
Supprelin (histrelin acetate)
(histrelin acetate)ENDO USA, Inc.
Usage: SUPPRELIN LA (histrelin acetate) is indicated for treating central precocious puberty (CPP) in children. It addresses early onset of secondary sexual characteristics and advanced bone age, which can affect adult height. Diagnosis must be confirmed through various hormonal and imaging assessments before initiating treatment.